期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 56, 期 24, 页码 9849-9860出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm401649j
关键词
-
资金
- Brazilian CAPES [8792127]
- Ligue Nationale Contre le Cancer
- Momentum Grant
- CNRS
- Universite Lyon 1 [UMR 5086]
- Ligue Nationale Contre le Cancer (Equipe labellisee Ligue)
- Region Rhone-Alpes (CIBLE)
- French ANR
- Hungarian NIH [2010-INT-1101-01]
We recently identified a chromone derivative, 5-(4-bromobenzyloxy)-2-(2-(5-methoxyindolypethyl-1-carbonyl)-4H-chromen-4-one, named here as chromone 1, as a potent, selective, nontoxic, and nontransported inhibitor of ABCG2-mediated drug efflux (Valdameri et al. J. Med. Chem. 2012, 55, 966). We have now synthesized a series of 14 derivatives to study the structure activity relationships controlling both drug efflux and ATPase activity of ABCG2 and to elucidate their molecular mechanism of interaction and inhibition. It was found that the 4-bromobenzyloxy substituent at position 5 and the methoxyindole are important for both inhibition of mitoxantrone efflux and inhibition of basal ATPase activity. Quite interestingly, methylation of the central amide nitrogen strongly altered the high affinity for ABCG2 and the complete inhibition of mitoxantrone efflux and coupled ATPase activity. These results allowed the identification of a critical central inhibitory moiety of chromones that has never been, investigated previously in any series of inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据